http://www.oxford-instruments.com/Pages/home.aspx


Oxford Instruments is a leading provider of high technology tools and systems for research and industry. We design and manufacture equipment that can fabricate, analyse and manipulate matter at the atomic and molecular level.

Oxford Instruments has discrete business groups operating in three sectors. This means we can focus our expertise, our technologies and our innovation on offering our customers high quality products and service that meet their stringent requirements.







Financial Calendar


Half Year/Interim Results Announcement

Tuesday November 13th 2012 : 9.30am The London Stock Exchange

Annual General Meeting:

Tuesday 11th September 2012 : 2.30pm

Oxford Instruments plc, Tubney Woods, Abingdon, Oxon OX13 4QX

26 September 2012 Ordinary shares quoted ex-dividend
28 September 2012 Record date for final dividend
30 September 2012 DRIP date
25 October 2012 Payment of final dividend
March 2013 Ordinary shares quoted ex-dividend
Dividend reinvestment (DRIP) last date for election
Record date for interim dividend
31 March 2013 Financial Year End

Interim's out tomorrow, wonder how much the foreign exchange rates are affecting these.

Stan, this was in Shares this week -The company designs and supplies some of the very high-technology tools and systems that scientists and researchers need to develop advanced applications. Its business model sees high-tech equipment sold into nanotechnology and industrial markets across the globe, and increasingly to Far East markets keen to expand their technological and scientific research base. This provides a vast and growing installed base from which after-sales parts and service revenues stem, generating highly visible and rising revenues. The company prides itself on turning smart science and innovation into commercially successful products, raising the barriers to entry for new competitors. Research spending cuts in Europe and the US have temporarily slammed the brakes on yet Oxford insists it remains on target to match its ’14 Cubed’ objectives (14% average revenue growth and return on sales, by 2014) (see The Big Debate, pages 36-37). Analysts at Numis point out: ‘Demand for Oxford’s products is being driven by the shift to smaller applications and the ability to analyse and manipulate matter at the atomic level.’ That means increasing nanotechnology research paid for with bigger and bigger budgets, in time. Numis estimates funding levels will increase between 10% and 20% a year going forward, underpinning EPS estimates it has for Oxford of 75.6p next year to March 2015, and 84.2p the year after. That implies a PE of 17.3 falling to 15.

Thanks for that DC, we will know tomorrow.

Half Year report http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11770744
http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail.html?announcementId=11770777

Oxford Instruments notes Andor response to bid 12 November 2013 | 15:19pm StockMarketWire.com - Oxford Instruments [LON:OXIG] notes the recent announcement made by Andor Technology plc [LON:AND]. Oxford Instruments has a high regard for the Andor business and its employees and is grateful for the Board of Andor's constructive engagement in the ongoing discussions. Oxford Instruments is developing its business in the Nano-Bio field and believes that the acquisition of Andor has significant industrial and commercial logic. Having substantially completed its due diligence, Oxford Instruments believes that the indicative offer of 500p per share in cash represents an attractive proposal to Andor shareholders. Oxford Instruments looks forward to continuing discussions with the Board of Andor and working with it towards a recommended transaction. At 3:19pm: [LON:OXIG] Oxford Instruments PLC share price was +164p at 1391p Story provided by StockMarketWire.com - See more at: http://www.stockmarketwire.com/article/4704413/Oxford-Instruments-notes-Andor-response-to-bid.html#sthash.r0GAiao3.dpuf



12 Nov N+1 Singer 1,425.00 Hold

Up nearly 9% on the day.

? 16.14% on the day. :-))

Really DC? Only just under 9% on my precent source, Which is not on here unfortunately at the moment.

Have you made 9% on the day Stan, is that what you mean. :-))


Current Share Price Information from OXIG company site.


Current (p) 1425.00

Change (p) 198.00

Change (%) 16.14

Best Bid (p) 1266.00

Best Offer (p) 1980.00

Day Volume 592,770

Chance a be a fine thing DC -): Just looked on their site and yes your right, wow what a rise! Can't remember are you in these at present?

No Stan :-((

You have Andor? well done then, you should be in the money.

:-))

Excellent.

Thought you would have been in this Stan.

Yes I did consider, but think I ducked out because my research indicated that they in past years have dipped at that time of year going forward.

Oxford Instruments’ halfway figures showed a dip in pre-tax profits and revenues as it was hit by curtailed government spending in the US and some low-margin industrial contracts that came to an end. Nevertheless, the dividend is up 10.2% to 3.36p, even though Oxford is not an income stock. Andor investors could consider taking profits, although The Times’ Tempus column says that it would tend to stay in to see what the situation brings.



http://sharecast.com/news/wednesday-tips-round-up-vodafone-andor-technology-bskyb/21289201.html

14 Nov Liberum Capital 1,650.00 Buy

Is it time to invest in Digital Britain? Five top technology shares to rival Twitter

By Marc Shoffman

PUBLISHED: 15:50, 15 November 2013 | UPDATED: 15:50, 15 November 2013


Oxford Instruments


Price-to-earnings ratio: 36.37


Dividend yield: 0.81 per cent


Share price as of 13 November: 1,462.00p

Most recent profits: £22m (31 March 2012)


The first technology business to be spun out from Oxford University over forty years ago, Oxford Instruments creates technology products for research


It was started in the garden shed of Sir Martin Wood in Oxford in 1959 to build superconducting magnets for scientific research. It got backing from Oxford University and listed in 1983.

The company’s best known projects include manufacturing the first commercial MRI scanner.


Mr Mould says: ‘Oxford Instruments’ business model sees high-tech equipment sold into nanotechnology and industrial markets across the globe, and increasingly to Far East markets keen to expand their technological and scientific research base. This provides a vast and growing installed base from which after-sales parts and service revenues stem, generating highly visible and rising revenues.


‘The company prides itself on turning smart science and innovation into commercially successful products, raising the barriers to entry for new competitors. Research spending cuts in Europe and the US have temporarily slammed the brakes on yet Oxford insists it remains on target to match its ’14 Cubed’ objectives of 14 per cent average revenue growth and return on sales, by 2014.'





http://www.dailymail.co.uk/money/investing/article-2505169/Five-UK-technology-stocks-rival-Twitter.html

Update on Possible Offer for Andor Technology plc

RNS


RNS Number : 0991U

Oxford Instruments PLC

27 November 2013






NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION



This is an announcement falling under Rule 2.4 of the City Code on Takeovers and Mergers (the "Code") and does not constitute an announcement of a firm intention to make an offer or to pursue any other transaction under Rule 2.7 of the Code. Accordingly, Andor Technology plc shareholders are advised that there can be no certainty that a formal offer for Andor Technology plc will be forthcoming, even in the event that the pre-conditions in this announcement are satisfied or waived.







27 November 2013





Oxford Instruments plc - Update on Possible Offer for Andor Technology plc



On 12 November 2013, Oxford Instruments plc ("Oxford Instruments" or the "Company") announced that it was in discussions with Andor Technology plc ("Andor") in relation to a possible offer for Andor.

Following the provision of further information including a meeting yesterday between senior management, Oxford Instruments announces that it has now completed its outstanding due diligence and has confirmed to the Board of Andor its proposed offer of 500 pence per share in cash to acquire the entire issued and to be issued share capital of Andor.

The making of any offer remains subject to the following pre-conditions:

i. the unanimous and unqualified recommendation by the Board of Andor in respect of any offer by Oxford Instruments; and

ii. the Directors of Andor giving irrevocable undertakings to accept any offer in respect of all of the Andor shares in which they are interested.

Oxford Instruments reserves the right to waive any or all of the pre-conditions described in this announcement. Even if all of these pre-conditions are satisfied or waived, there can be no certainty that a firm offer will be forthcoming.

Facilities to allow Oxford Instruments to provide certain funds in support of the offer have been negotiated and can be executed at short notice.

Further, Oxford Instruments reserves the right to make an offer on less favourable terms than those set out in this announcement in the event that:

i. Andor announces, declares, pays or makes any dividend or distribution to Andor shareholders at any time, in which case there will be an equivalent reduction in Oxford Instruments' offer price; or

ii. the issued and to be issued share capital of Andor is greater than the 33.2 million shares that has been assumed, such that the pro rata entitlement per Andor share is lower than 500 pence.

Rule 2.6(a) of the Code, requires that Oxford Instruments, by not later than 5.00 p.m. on 10 December2013 (the "relevant deadline"), either announces a firm intention to make an offer for Andor in accordance with Rule 2.7 of the Code or announces that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.